ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates

This quarterly report represents an earnings surprise of 1,400%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of$0.20, delivering a surprise of -11.11%. ARS Pharmaceuticals, Inc. (SPRY) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of a loss of$0.04 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. Empirical research shows a ...